These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36763961)

  • 1. Symptoms and associated impact in pre- and postmenopausal women with sexual arousal disorder: a concept elicitation study.
    Symonds T; Kingsberg SA; Simon JA; Kroll R; Althof SE; Parish SJ; Cornell KA; Johnson IF; Goldstein AT
    J Sex Med; 2023 Feb; 20(3):277-286. PubMed ID: 36763961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase 2a multicenter, double-blind, placebo-controlled, crossover trial to investigate the efficacy, safety, and toleration of CP-866,087 (a high-affinity mu-opioid receptor antagonist) in premenopausal women diagnosed with female sexual arousal disorder (FSAD).
    Orri M; Abraham L; Giraldi A
    J Sex Med; 2013 Oct; 10(10):2484-96. PubMed ID: 23347610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Responder Analyses from a Phase 2b Dose-Ranging Study of Bremelanotide.
    Althof S; Derogatis LR; Greenberg S; Clayton AH; Jordan R; Lucas J; Spana C
    J Sex Med; 2019 Aug; 16(8):1226-1235. PubMed ID: 31277966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The sensitivity of event logs, self-administered questionnaires and photoplethysmography to detect treatment-induced changes in female sexual arousal disorder (FSAD) diagnosis.
    Rellini A; Meston C
    J Sex Med; 2006 Mar; 3(2):283-91. PubMed ID: 16490021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal evaluation of sexual function in a cohort of pre- and postmenopausal women.
    Burri A; Hilpert P; Spector T
    J Sex Med; 2015 Jun; 12(6):1427-35. PubMed ID: 25940696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling and simulation of sexual activity daily diary data of patients with female sexual arousal disorder treated with sildenafil citrate (Viagra).
    Claret L; Cox EH; McFadyen L; Pidgen A; Johnson PJ; Haughie S; Boolell M; Bruno R
    Pharm Res; 2006 Aug; 23(8):1756-64. PubMed ID: 16841199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treating symptoms of female sexual arousal disorder with the Eros-Clitoral Therapy Device.
    Wilson SK; Delk JR; Billups KL
    J Gend Specif Med; 2001; 4(2):54-8. PubMed ID: 11480099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the Severity of Overactive Bladder Symptoms Correlate With Risk for Female Sexual Dysfunction?
    Juliato CRT; Melotti IGR; Junior LCS; Britto LGO; Riccetto CLZ
    J Sex Med; 2017 Jul; 14(7):904-909. PubMed ID: 28622875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Female sexual arousal disorder with and without a distress criterion: prevalence and correlates in a representative Czech sample.
    Weiss P; Brody S
    J Sex Med; 2009 Dec; 6(12):3385-94. PubMed ID: 19758283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychosexual Correlates of Unwanted Sexual Experiences in Women Consulting for Female Sexual Dysfunction According to Their Timing Across the Life Span.
    Maseroli E; Scavello I; Campone B; Di Stasi V; Cipriani S; Felciai F; Camartini V; Magini A; Castellini G; Ricca V; Maggi M; Vignozzi L
    J Sex Med; 2018 Dec; 15(12):1739-1751. PubMed ID: 30446470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intended or unintended consequences? The likely implications of raising the bar for sexual dysfunction diagnosis in the proposed DSM-V revisions: 2. For women with loss of subjective sexual arousal.
    Clayton AH; DeRogatis LR; Rosen RC; Pyke R
    J Sex Med; 2012 Aug; 9(8):2040-6. PubMed ID: 23586432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partners Experience Consequences, Too: A Comparison of the Sexual, Relational, and Psychological Adjustment of Women with Sexual Interest/Arousal Disorder and Their Partners to Control Couples.
    Rosen NO; Dubé JP; Corsini-Munt S; Muise A
    J Sex Med; 2019 Jan; 16(1):83-95. PubMed ID: 30509505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparison of Medical Comorbidities, Psychosocial, and Sexual Well-being in an Online Cross-Sectional Sample of Women Experiencing Persistent Genital Arousal Symptoms and a Control Group.
    Jackowich RA; Poirier É; Pukall CF
    J Sex Med; 2020 Jan; 17(1):69-82. PubMed ID: 31680008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between personality traits and sexual function in symptomatic postmenopausal women.
    Barbagallo F; Cucinella L; Tiranini L; Martini E; Bosoni D; Molinaro P; Battista F; Albani F; Calogero AE; Nappi RE
    Maturitas; 2022 Dec; 166():50-57. PubMed ID: 36057183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual function questionnaire: further refinement and validation.
    Symonds T; Abraham L; Bushmakin AG; Williams K; Martin M; Cappelleri JC
    J Sex Med; 2012 Oct; 9(10):2609-16. PubMed ID: 22248074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of premenopausal and postmenopausal women with acquired, generalized hypoactive sexual desire disorder: the Hypoactive Sexual Desire Disorder Registry for women.
    Rosen RC; Maserejian NN; Connor MK; Krychman ML; Brown CS; Goldstein I
    Menopause; 2012 Apr; 19(4):396-405. PubMed ID: 22076307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated With Specific Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition Sexual Dysfunctions in Breast Cancer Survivors: A Study of Patients and Their Partners.
    Hummel SB; Hahn DEE; van Lankveld JJDM; Oldenburg HSA; Broomans E; Aaronson NK
    J Sex Med; 2017 Oct; 14(10):1248-1259. PubMed ID: 28923310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study.
    Berman JR; Berman LA; Toler SM; Gill J; Haughie S;
    J Urol; 2003 Dec; 170(6 Pt 1):2333-8. PubMed ID: 14634409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sexual dysfunction among reproductive-aged Chinese married women in Hong Kong: prevalence, risk factors, and associated consequences.
    Zhang H; Fan S; Yip PS
    J Sex Med; 2015 Mar; 12(3):738-45. PubMed ID: 25470214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward a More Evidence-Based Nosology and Nomenclature for Female Sexual Dysfunctions-Part III.
    Parish SJ; Meston CM; Althof SE; Clayton AH; Goldstein I; Goldstein SW; Heiman JR; McCabe MP; Segraves RT; Simon JA
    J Sex Med; 2019 Mar; 16(3):452-462. PubMed ID: 30846116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.